This approach targets multiple exons that, upon skipping, give rise to a protein that is able to fold properly, as demonstrated in studies addressing Duchenne muscular dystrophy (DMD), CADASIL (NOTCH3), Miyoshi-myopathy (DYSF), and USH2A (USH2A).10 This evidence concerns the gene DYSF and Duchenne muscular dystrophy.